Jennewein Biotechnologie and Pfizer Nutrition Collaborate on Human Milk Components / License Agreement Provides Rights to Pfizer Nutrition for Innovative, Biologically-Sourced Human Milk Components

Rheinbreitbach (ots) - Jennewein Biotechnologie today announced
that the company has signed a license agreement with Pfizer Nutrition
to develop and market two Human Milk Oligosaccharides (HMOs).

Human Milk Oligosaccharides represent a major component of
mother's milk, and provide short and long-term benefits to infants
from birth onwards. Scientific research has shown that HMOs can
significantly lower infants' risk of infection during the time of
lactation. In addition, these compounds are known to influence
colonization of beneficial bacteria and support healthy immune
development.

The partnership will focus on enabling the functional and
immunological benefits of HMOs to become available to infants being
fed with infant formulas. Human milk, the "gold standard" due to its
special composition of lipids, proteins and HMOs, is the best
nutrition for infants.

"Building upon nearly a century as pioneers in infant nutritional
science, we are constantly striving to more closely replicate the
composition and functional benefits of breast milk, and this
partnership truly helps further this mission," stated John Troup,
PhD, Vice President, Global Research & Development, Pfizer Nutrition.

Dr. Stefan Jennewein, Managing Director and Cofounder of Jennewein
Biotechnologie, underlines, "Complex oligosaccharides in general and
HMOs in particular show an enormous potential for use in human
nutrition. The cooperation between Pfizer Nutrition and Jennewein
Biotechnologie will accelerate the developments in this field by
bringing together specific complementary competencies."

Jennewein plans to also focus on adult nutrition, in addition to
infant formulas, in the commercialization of HMOs so as to bring the
benefits of this natural product to a broader group of consumers.

About Jennewein Biotechnologie

Jennewein Biotechnologie GmbH, found in 2005 in Rheinbreitbach
(Germany), is a science based company in the field of industrial
biotechnology. The company is focusing its activities on the
development of innovative production processes for scarce and complex
mono- and oligosaccharides. The mission of Jennewein Biotechnologie
is to provide sugars with scientifically proven health benefits and
to make these available to larger consumer groups.

About Pfizer Nutrition

Pfizer Nutrition, formerly Wyeth Nutrition, is part of Pfizer Inc.
Pfizer Nutrition supports the company's mission to improve health and
well-being at every stage of life, bringing breadth and depth of
consumer and scientific insight to new populations and new markets
around the world. Pfizer Nutrition brings together almost a century
of experience in which the company has leveraged clinical rigor,
scientific research, world class manufacturing and product safety
standards to drive scientifically-sound solutions that offer parents
confidence, help nourish children and support their healthy futures.
We develop premium-quality nutritional products that are
scientifically-designed to meet the needs of infants and young
children, as well as pregnant and lactating mothers.

Media Inquiries:
Jennewein Biotechnologie GmbH
Amélie Jennewein
Maarweg 32
53619 Rheinbreitbach
Germany
Tel. +49- (0)2224 / 967.9669
Fax. +49- (0)2224 / 988.0854
Email: info@jennewein-biotech.de
www.jennewein-biotech.de